| |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 15/24 | Apr 15/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 527 | $8.84 |
Mar 28/24 | Mar 27/24 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | -25,685 | $9.17 |
Mar 28/24 | Mar 27/24 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | 25,685 | $9.17 |
Mar 25/24 | Mar 20/24 | Mailling, Ryan | Direct Ownership | Options | 50 - Grant of options | 20,000 | $8.15 |
Mar 25/24 | Mar 20/24 | Mull, Craig | Direct Ownership | Options | 50 - Grant of options | 132,575 | $8.15 |
Mar 25/24 | Mar 20/24 | Jacobs, Bryan | Direct Ownership | Options | 50 - Grant of options | 50,000 | $8.15 |
Mar 19/24 | Mar 18/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 606 | $7.69 |
Feb 20/24 | Feb 16/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 667 | $6.98 |
Jan 18/24 | Jan 15/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 795 | $5.86 |
Jan 2/24 | Dec 29/23 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | -60,372 | $6.20 |
Sign up or login above to see all SEDI filings within the past 6 months. |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 15/24 | Apr 15/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 527 | $8.84 |
Mar 28/24 | Mar 27/24 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | -25,685 | $9.17 |
Mar 28/24 | Mar 27/24 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | 25,685 | $9.17 |
Mar 25/24 | Mar 20/24 | Mailling, Ryan | Direct Ownership | Options | 50 - Grant of options | 20,000 | $8.15 |
Mar 25/24 | Mar 20/24 | Mull, Craig | Direct Ownership | Options | 50 - Grant of options | 132,575 | $8.15 |
Mar 25/24 | Mar 20/24 | Jacobs, Bryan | Direct Ownership | Options | 50 - Grant of options | 50,000 | $8.15 |
Mar 19/24 | Mar 18/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 606 | $7.69 |
Feb 20/24 | Feb 16/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 667 | $6.98 |
Jan 18/24 | Jan 15/24 | Wolkin, Harold Morton | Direct Ownership | Common Shares | 30 - Acquisition under a purchase/ownership plan | 795 | $5.86 |
Jan 2/24 | Dec 29/23 | Cipher Pharmaceuticals Inc. | Direct Ownership | Common Shares | 38 - Redemption, retraction, cancellation, repurchase | -60,372 | $6.20 |
Sign up or login above to see all SEDI filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. |
Competitors with Recent Insider Filings |
Cresco Labs (C:CL*CA) |
Cytophage Technologies (V:CYTO*CA) |
BioSyent (V:RX*CA) |